These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22 related articles for article (PubMed ID: 15631670)
1. Selective killing of IL6 receptor bearing myeloma cells using recombinant IL6-Pseudomonas toxin. Siegall CB; FitzGerald DJ; Pastan I Curr Top Microbiol Immunol; 1990; 166():63-9. PubMed ID: 2127396 [No Abstract] [Full Text] [Related]
2. Cell-specific toxicity of a chimeric protein composed of interleukin-6 and Pseudomonas exotoxin (IL6-PE40) on tumor cells. Siegall CB; Nordan RP; FitzGerald DJ; Pastan I Mol Cell Biol; 1990 Jun; 10(6):2443-7. PubMed ID: 2160579 [TBL] [Abstract][Full Text] [Related]
3. [Construction, bioactivity identification and structural characteristics analysis of a novel recombinant immunosuppression protein B7-2-L-PE40KDEL]. Yuan Z; Xi Y; Zhang H; Kong F; Guan H; Guo S; Liu N; Liang F; Sun Y; Cui J Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1541-5. PubMed ID: 12609063 [TBL] [Abstract][Full Text] [Related]
4. [Establishment of purification procedure for recombinant fusion protein B7-2-PE40KDEL]. Guan HR; Sun YY; Yuan ZH; Zhang HL; Liang F; Liu N; Guo SQ; Xi CX; Xi YZ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):123-7. PubMed ID: 16584607 [TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma, PLC/PRF/5 in mice. Siegall CB; Kreitman RJ; FitzGerald DJ; Pastan I Cancer Res; 1991 Jun; 51(11):2831-6. PubMed ID: 1851660 [TBL] [Abstract][Full Text] [Related]
6. Expression of interleukin-6 receptors by pediatric acute lymphoblastic leukemia cells with the t(4;11) translocation: a possible target for therapy with recombinant IL6-Pseudomonas exotoxin. Gu L; Zhou M; Jurickova I; Yeager AM; Kreitman RJ; Phillips CN; Findley HW Leukemia; 1997 Oct; 11(10):1779-86. PubMed ID: 9324301 [TBL] [Abstract][Full Text] [Related]
7. [Specific cytotoxicity of recombinant interleukin 6-pseudomonas exotoxin fusion protein (IL6-PE40) on LT12 leukemic cells expressing high levels of interleukin 6 receptor (IL6R)]. Xi YZ Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):419-22. PubMed ID: 8200278 [TBL] [Abstract][Full Text] [Related]
8. [Biochemical and physical properties for a recombinant IL6 Pseudomonas exotoxin fusion protein IL6D24-PE40KDEL]. Cui JW; Guo SQ; Sun YY; Liu N; Liang F; Xi YZ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):825-8. PubMed ID: 15631670 [TBL] [Abstract][Full Text] [Related]
9. [Molecular design and construction of IL6D24-PE40KDEL, a novel recombinant interleukin6-pseudomonas exotoxin fusion protein, having targeted cytotoxicity for leukemias expressing interleukin6 receptors]. Zheng LY; Xi YZ; Kong FH; Cui JW; Liang F; Liu N; Sun YY; Guo SQ Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1246-50. PubMed ID: 12930640 [TBL] [Abstract][Full Text] [Related]
10. Molecular construction and characterization of a novel exotoxin fusion protein that selectively blocks the B7:CD28 costimulatory signal system. Xi Y; Yuan Z; Zhang H; Guan H; Kong F; Liu N; Liang F; Cui J; Guo S; Sun Y; Xi C J Immunother; 2006; 29(6):586-95. PubMed ID: 17063121 [TBL] [Abstract][Full Text] [Related]
11. A novel fusion toxin derived from an EpCAM-specific designed ankyrin repeat protein has potent antitumor activity. Martin-Killias P; Stefan N; Rothschild S; Plückthun A; Zangemeister-Wittke U Clin Cancer Res; 2011 Jan; 17(1):100-10. PubMed ID: 21075824 [TBL] [Abstract][Full Text] [Related]